Teva Stock Gains. The Company Will Divest Drug Ingredients Business.
Teva has struggled for years with enormous debts and litigation over its role in the opioid crisis.
Josh Nathan Kazis David Williams Bloomberg Richard Francis Teva Adrs Teva Pharmaceutical Industries Wall Street
Source: marketwatch.com